(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 32.84%-1.28M | 6.75%-913.44K | -31.50%-5.2M | -40.74%-8.52M | -0.21%-1.68M | 6.78%-1.9M | -15.22%-979.53K | -166.43%-3.96M | -5.68%-6.05M | 41.31%-1.68M |
Net income from continuing operations | -299.31%-10.3M | -81.70%-5.73M | -266.58%-6.65M | 47.09%-11.45M | -112.38%-3.9M | 80.10%-2.58M | -11.01%-3.15M | 54.61%-1.81M | -57.76%-21.63M | 56.47%-1.84M |
Operating gains losses | 3,736.55%5.76M | 668.29%1.13M | 910.98%1.87M | -61.57%590.75K | -42.41%109.05K | -42.03%150.24K | -29.51%146.48K | -79.00%184.98K | -44.24%1.54M | -84.99%189.37K |
Depreciation and amortization | 2.70%170.34K | -0.66%170.34K | 2.32%170.34K | 64.80%679.38K | 45.43%175.56K | 68.58%165.87K | 74.27%171.47K | 75.69%166.48K | 21.02%412.25K | 29.51%120.72K |
Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --9.89M | --1 |
Remuneration paid in stock | 147.66%2.22M | 77.38%2.16M | 147.99%1.85M | -12.04%4.47M | 96.95%1.61M | -33.80%897.83K | -15.25%1.21M | -49.37%744.99K | 10.90%5.08M | -41.72%817.22K |
Other non cashItems | 118.56%143.04K | 120.41%127.19K | 104.54%83.63K | -7.46%-3.13M | 105.91%107.26K | -36.21%-770.68K | -77.76%-623.22K | -920.61%-1.84M | -1,354.93%-2.91M | -1,023.39%-1.82M |
Change In working capital | 205.89%721.58K | -2.15%1.24M | -81.02%-2.53M | -79.76%317.96K | -74.40%216.4K | 302.91%235.9K | 110.50%1.26M | -676.28%-1.4M | 2,037.20%1.57M | 168.29%845.42K |
-Change in receivables | 54.10%-93.62K | -21.66%618.45K | -444.47%-52.03K | -199.04%-384.78K | -2,050.18%-985.4K | -15.27%-203.96K | 843.90%789.48K | 117.59%15.11K | -166.88%-128.67K | 26.20%50.53K |
-Change in payables and accrued expense | 85.33%815.19K | 30.41%616.75K | -75.40%-2.48M | -58.66%702.74K | 51.19%1.2M | 624.78%439.85K | -8.36%472.92K | -530.09%-1.41M | 1,530.23%1.7M | 162.19%794.89K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 32.84%-1.28M | 6.75%-913.44K | -31.50%-5.2M | -40.74%-8.52M | -0.21%-1.68M | 6.78%-1.9M | -15.22%-979.53K | -166.43%-3.96M | -5.68%-6.05M | 41.31%-1.68M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -9.33%-120.17M | -17.43%-124.56M | -76.40%-128.89M | -332.24%-418.37M | -205.72%-129.32M | -229.77%-109.91M | -589.16%-106.07M | -1,166.50%-73.07M | -21.51%-96.79M | -375.30%-42.3M |
Net PPE purchase and sale | -8.60%-118.4M | -17.15%-123.04M | -82.92%-129.52M | -309.05%-396.42M | -154.86%-111.55M | -261.71%-109.03M | -570.45%-105.03M | -865.34%-70.81M | -15.86%-96.91M | -384.20%-43.77M |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -58.33%1.38M | --0 |
Interest received (cash flow from investment activities) | -28.23%852.46K | 145.38%1.49M | -12.36%1.78M | 35.97%3.6M | -114.65%-225.29K | 100.45%1.19M | 81.43%609.19K | 1,013.23%2.03M | 178.85%2.65M | 679.28%1.54M |
Net other investing changes | -26.36%-2.62M | -82.49%-3.01M | 73.31%-1.14M | -553.54%-25.55M | -25,471.44%-17.54M | 45.17%-2.07M | -2,593.09%-1.65M | ---4.29M | -1,279.12%-3.91M | -19.30%-68.6K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -9.33%-120.17M | -17.43%-124.56M | -76.40%-128.89M | -332.24%-418.37M | -205.72%-129.32M | -229.77%-109.91M | -589.16%-106.07M | -1,166.50%-73.07M | -21.51%-96.79M | -375.30%-42.3M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -82.73%20.91M | 28.49%82.21M | 1,360.50%132.01M | 135.18%389.4M | 25.74%214.78M | 19,313.69%121.11M | 12,715.41%63.98M | -145.26%-10.47M | 0.41%165.58M | 14,390.85%170.8M |
Net issuance payments of debt | -644.00%-1.44M | 20,713.30%79.19M | 76,470.40%129.42M | 41,198.09%148.72M | 163,793.66%149.47M | -113.58%-192.98K | -325.18%-384.17K | -88.61%-169.47K | -22.04%-361.87K | -25.97%-91.31K |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 2.27%175.01M | ---- |
Proceeds from stock option exercised by employees | 5,192.96%22.35M | -31.41%3.26M | 9,112.96%3.28M | 2,177.52%8.62M | --3.41M | 160.62%422.2K | 3,549.77%4.75M | -58.75%35.64K | -79.84%378.6K | --0 |
Net other financing activities | ---- | -100.40%-235.69K | 93.28%-694.74K | 2,556.52%232.05M | 1,605.65%61.89M | 17,320.04%120.88M | 10,998.01%59.61M | -142.32%-10.34M | -20.99%-9.45M | -149.70%-4.11M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -82.73%20.91M | 28.49%82.21M | 1,360.50%132.01M | 135.18%389.4M | 25.74%214.78M | 19,313.69%121.11M | 12,715.41%63.98M | -145.26%-10.47M | 0.41%165.58M | 14,390.85%170.8M |
Net cash flow | ||||||||||
Beginning cash position | 75.14%111.25M | 44.96%154.51M | -19.32%156.59M | 47.75%194.09M | 8.25%72.82M | -38.49%63.52M | -11.05%106.59M | 47.75%194.09M | 153.36%131.36M | -53.39%67.27M |
Current changes in cash | -1,181.40%-100.53M | -0.44%-43.26M | 97.62%-2.08M | -159.78%-37.5M | -33.95%83.77M | 125.83%9.3M | -157.15%-43.07M | -659.22%-87.5M | -21.11%62.73M | 1,078.75%126.82M |
End cash Position | -85.28%10.72M | 75.14%111.25M | 44.96%154.51M | -19.32%156.59M | -19.32%156.59M | 8.25%72.82M | -38.38%63.52M | -11.05%106.59M | 47.75%194.09M | 47.75%194.09M |
Free cash from | -7.89%-119.68M | -16.93%-123.96M | -80.20%-134.72M | -293.27%-404.94M | -149.15%-113.24M | -244.71%-110.93M | -541.87%-106.01M | -747.66%-74.76M | -15.21%-102.97M | -281.87%-45.45M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data